LEADER 05565nam 2200685Ia 450 001 9910438135203321 005 20200520144314.0 010 $a1-283-61269-0 010 $a9786613925145 010 $a3-7091-1192-7 024 7 $a10.1007/978-3-7091-1192-5 035 $a(CKB)2560000000091012 035 $a(EBL)973911 035 $a(OCoLC)809767743 035 $a(SSID)ssj0000740650 035 $a(PQKBManifestationID)11930764 035 $a(PQKBTitleCode)TC0000740650 035 $a(PQKBWorkID)10701144 035 $a(PQKB)10150851 035 $a(DE-He213)978-3-7091-1192-5 035 $a(MiAaPQ)EBC973911 035 $a(PPN)168331349 035 $a(EXLCZ)992560000000091012 100 $a20120911d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCerebral vasospasm $eneurovascular events after subarachnoid hemorrhage /$fedited by Mario Zuccarello ... [et al.] 205 $a1st ed. 2013. 210 $aVienna ;$aNew York $cSpringer$dc2013 215 $a1 online resource (324 p.) 225 1 $aActa Neurochirurgica. Supplements,$x0065-1419 ;$v115 300 $aInternational conference proceedings. 311 $a3-7091-1739-9 311 $a3-7091-1191-9 320 $aIncludes bibliographical references and indexes. 327 $aCerebral Vasospasm: Neurovascular Events After Subarachnoid Hemorrhage; Copyright page; Preface; Acknowledgment; Contents; Frank H. May field, MD, FACS, FAANS (1909-1991): 75th Anniversary Tribute; References; History and Definition of Delayed Cerebral Ischemia; Introduction; The Vasospasm Meetings; Early Descriptions; Advances; Controversies; Definitions; Conclusion; References; Clinical, Transcranial Doppler Ultrasound, Radiological Features and, Prognostic Significance of Delayed Cerebral Ischemia; Introduction; Methods; Statistical Analysis; Results; Discussion; References 327 $aIdentifying Patient Report Outcomes Relevant to Aneurysmal Subarachnoid Hemorrhage Follow-UpIntroduction; Methods; Results; Discussion; Conclusions; References; Global Cerebral Atrophy After Subarachnoid Hemorrhage: A Possible Marker of Acute Brain Injury and Assessment of Its Impact on Outcome; Introduction; Methods; Results; Conclusion; References; Protein Biomarkers in Patients with Subarachnoid Hemorrhage, Vasospasm, and Delayed Ischemic Neurological Deficits; Introduction; Methods; Patient Population; Diagnosis of Nontraumatic Subarachnoid Hemorrhage, Vasospasm, and DIND 327 $aSerum Protein Pro fi lesAntibody Array; Results; Conclusion; References; Randomised Trial of Clazosentan, an Endothelin Receptor Antagonist, in Patients with Aneurysmal Subarachnoid Hemorrhage Undergoing Surgical Clipping (CONSCIOUS-2); Introduction; Methods; Results; Discussion; Conclusion; References; Angiographic Vasospasm Versus Cerebral Infarction as Outcome Measures After Aneurysmal Subarachnoid Hemorrhage; Introduction; Methods; Meta-analyses; Exploratory Cohort Analysis; Results; Angiographic Vasospasm and Poor Clinical Outcome Meta-analysis 327 $aCerebral Infarction and Poor Clinical Outcome Meta-analysisExploratory Cohort Analysis; Discussion; Conclusion; References; Development of Nicardipine Prolonged-Release Implants After Clipping for Preventing Cerebral Vasospasm: From Laboratory to Clinical Trial; Introduction; Preliminary Study Using Papaverine; In Vitro Study; Animal Model; Canine Clot Placement Model; Canine Double-Hemorrhage Model; Clinical Trial; The First Consecutive 100 Patients; Single-Center, Randomized, Double-Blind Trial; Multicenter Cooperative Study in Tokyo; Discussion; Conclusion; References 327 $aMagnesium Sulphate for Aneurysmal Subarachnoid Hemorrhage: Why, How, and Current ControversyIntroduction; Proposed Mechanism of Action; Administration Routes; Conclusion; References; Prolonged Intravenous Infusion of Sodium Nitrite Delivers Nitric Oxide (NO) in Humans; Introduction; Materials and Methods; Results; Sodium Nitrite Infusion; Discussion; Conclusion; References; Proposed Mechanism of Cerebral Vasospasm: Our Hypothesis and Current Topics; Introduction; Mechanism Underlying Increased Vascular Contractility After SAH; Endothelial Damage and Dysfunction 327 $aUpregulation of Receptor Expression 330 $aThe book contains 48 articles presented at the 11th International Conference on Cerebral Vasospasm held in Cincinnati, Ohio, USA, in July 2011. This collection of papers represents a cross-section of the enormous progress that has been made towards a thorough understanding and effective treatment of neurovascular events following aneurysmal subarachnoid hemorrhage, including cerebral vasospasm. It is of interest to clinicians who wish to apply state-of-the-art knowledge to their management of this devastating condition and to basic scientists wishing to expand their understanding of cerebrovascular and neural pathophysiology related to subarachnoid hemorrhage. 410 0$aActa neurochirurgica.$pSupplement ;$v115. 606 $aCerebrovascular spasm$vCongresses 606 $aSubarachnoid hemorrhage$vCongresses 615 0$aCerebrovascular spasm 615 0$aSubarachnoid hemorrhage 676 $a616.81 701 $aZuccarello$b Mario$01749930 712 12$aInternational Conference on Cerebral Vasospasm 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910438135203321 996 $aCerebral vasospasm$94184394 997 $aUNINA